Skip to main content

Table 5 Occurrence of antimicrobial resistance among Escherichia coli isolated from healthy pigs in different European countries.

From: Occurrence of antimicrobial resistance among bacterial pathogens and indicator bacteria in pigs in different European countries from year 2002 – 2004: the ARBAO-II study

Antimicrobial agent

Year

Country and prevalence of resistance

  

A

B

DK

FIN

F

I

NL

N

PL

ES

S

Ampicillin

2002

-

62

10.9

-

31.0

-

25.5

5.9

-

56.7

-

 

2003

-

-

22.7

-

26.5

46.0

27.7 a

-

-

68.4

3.0

 

2004

6.0

-

33.2

6.0

22.0

54.2

25.3

8.0

9.5

69.9

-

Amoxicillin + Clavulanic acid

2002

-

1

-

-

-

-

-

-

-

2.4

-

 

2003

-

-

0.3

-

-

1.0

-

-

-

0.7

0.3

 

2004

0.0

-

1.0

-

-

1.2

-

-

-

0.0

-

Apramycin

2002

-

4

0.3

-

2.0

-

-

0.0

-

5.9

-

 

2003

-

-

0.9

-

9.1

-

-

-

-

4.2

0.0

 

2004

1.8

-

3.4

-

4.0

-

-

-

-

4.9

-

Ceftiofur

2002

-

1

0.0

-

-

-

0.0

0.0

-

0.0

-

 

2003

-

-

0.0

-

-

0.0

0.6 a

-

-

0.0

0.0

 

2004

0.0

-

0.0

0.0

-

0.0

0.3

0.0

0.6

0.5

-

Chloramphenicol

2002

-

33

3.7

-

21.0

-

9.4

0.5

-

30.5

-

 

2003

-

-

6.7

-

21.4

26.0

7.7 a

-

-

37.9

0.7

 

2004

3.7

-

9.1

1.0

14.0

28.9

12.2

0.8

2.5

30.6

-

Ciprofloxacin

2002

-

2

0.0

-

0.0

-

0.0

0.0

-

1.7

-

 

2003

-

-

1.8

-

0.0

1.0

0.0a

-

-

1.1

1.0

 

2004

0.9

-

0.0

0.0

1.0

5.4

0.0

0.0

2.5

3.3

-

Florfenicol

2002

-

1

0.0

-

1.0

-

0.0

0.0

-

0.7

-

 

2003

-

-

0.0

-

2.0

-

0.6a

-

-

2.1

0.0

 

2004

0.0

-

0.0

0.0

1.0

-

0.0

0.0

2.0

2.2

-

Gentamicin

2002

-

3

0.3

-

0.0

-

1.3

0.0

-

4.8

-

 

2003

-

-

0.6

-

3.1

2.0

1.3a

-

-

5.3

0.0

 

2004

0.9

-

3.4

0.0

0.0

1.2

0.3

0.0

0.6

7.7

-

Nalidixic acid

2002

-

5

1.0

-

5.0

-

1.0

0.5

-

12.8

-

 

2003

-

-

1.9

-

7.1

8.0

0 a

-

-

14.4

1.0

 

2004

2.3

-

3.4

1.0

3.0

6.6

1.7

0.0

6.4

20.8

-

Neomycin

2002

-

0

3.0

-

1.0

-

1.3

0.5

-

14.5

-

 

2003

-

-

5.7

-

5.9

-

3.2a

-

-

13.7

1.0

 

2004

2.3

-

15.8

1.0

5.0

-

2.0

0.8

-

11.5

-

Streptomycin

2002

-

46

33.8

-

65.0

-

-

20.8

-

70.9

-

 

2003

-

-

43.9

-

67.0

49.0

-

-

-

72.3

13.0

 

2004

54.4

-

47.6

15.0

62.0

48.2

-

33.6

34.7

66.1

-

Sulphonamides

2002

-

73

23.2

-

-

-

-

10.7

-

70.6

-

 

2003

-

-

30.6

-

-

51.0

-

-

-

77.5

9.0

 

2004

30.0

-

46.6

12.0

-

-

52.7

12.0

15.9

73.2

-

Tetracycline

2002

-

80

25.9

-

89.0

-

57.7

7.4

-

91.0

-

 

2003

-

-

30.2

-

81.2

66.0

69.7 a

-

-

93.0

12.0

 

2004

58.1

-

43.8

16.0

86.0

81.0

63.9

9.6

31.6

95.6

-

Trimethoprim

2002

-

68

6.1

-

61.0

-

43.0

4.8

-

69.2

-

 

2003

-

-

13.6

-

48.0

-

43.9 a

-

-

76.5

4.0

 

2004

3.4

-

-

8.0

44.0

-

5.7

4.0

1.0

66.7

-

Trimethoprim + Sulphonamides

2002

-

-

-

-

-

-

41.6

-

-

-

-

 

2003

-

-

-

-

-

49.0

43.2 a

-

-

-

-

 

2004

-

-

49.0

-

-

47.6

43.9

-

13

72.3

-

  1. -: No data available, a: faeces. A – Austria; B – Belgium, DK – Denmark, E – England including Wales; F – France; FIN – Finland; I – Italy; NL – The Netherlands; N – Norway; PL – Poland; ES – Spain; S – Sweden.